Home
Watchlist
News
Signals
Picks
DJI
-0.34%
SPX
+0.32%
IXIC
+0.87%
FTSE
+0.65%
N225
-0.88%
AXJO
-1.82%
Log In
Get Started
Home
Watchlist
News
Signals
Picks
Stocks
Add to Watchlist
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.
Company
About Us
Careers
Blog
News
Help & Support
Help Center
Contact Us
Pro Support
Legal
Privacy Policy
Terms of Use
Instagram
YouTube
© 2024 Cashu PTY LTD.
Join our newsletter to keep up to date with us!
Sign Up
Signals
SRPT
Sarepta Therapeutics
5 days ago
SRPT is now overvalued and could go down -38%
-0.93%
📡️ Health Care
SRPT
Sarepta Therapeutics
12 days ago
SRPT has been in the news 321% more than usual
-10.14%
📡️ Health Care
SRPT
Sarepta Therapeutics
27 days ago
Analysts think SRPT stock price could increase by 16%
11.82%
📡️ Health Care
SRPT
Sarepta Therapeutics
28 days ago
SRPT beat EPS expectations by 146.83%
0.00%
📡️ Health Care
SRPT
Sarepta Therapeutics
about 1 month ago
SRPT has been in the news 313% more than usual
4.33%
📡️ Health Care
SRPT
Sarepta Therapeutics
about 1 month ago
SRPT has been in the news 316% more than usual
44.35%
📡️ Health Care
SRPT
Sarepta Therapeutics
about 1 month ago
SRPT has been in the news 321% more than usual
48.98%
📡️ Health Care
SRPT
Sarepta Therapeutics
about 2 months ago
SRPT has been in the news 625% more than usual
55.05%
📡️ Health Care
SRPT
Sarepta Therapeutics
about 2 months ago
SRPT has been in the news 563% more than usual
-19.61%
📡️ Health Care
SRPT
Sarepta Therapeutics
about 2 months ago
Analysts think SRPT stock price could increase by 152%
-8.22%
📡️ Health Care
SRPT
Sarepta Therapeutics
3 months ago
SRPT has been in the news 682% more than usual
1.36%
📡️ Health Care
SRPT
Sarepta Therapeutics
3 months ago
SRPT has been in the news 750% more than usual
-5.11%
📡️ Health Care
Stocks
Health Care
srpt
Add to Watchlist
Sarepta Therapeutics
NASDAQ: SRPT
+0.27 (+1.46%)
18.425
USD
At close at Sep 03, 15:38 UTC
Summary
News
Signals
Benchmarks
Financials